<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated using Ez-XBRL version 7.0.2.4 [08/16/2013 05:58:07 PM] -->
<!-- Based on XBRL 2.1 -->
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Saturday, August 17, 2013 12:07:06 AM -->
<xbrli:xbrl xmlns:bcke="http://www.0000949721.com/20130630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="bcke-20130630.xsd"/>
<!-- Context Section  -->

<xbrli:context id="Context_3ME__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2012_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-04-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2013_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueGoodsNetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-04-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2013_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-04-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_BoardOfDirectorsChairmanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__12-Aug-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-08-12
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>MrlsywiI~\FVPc444c555cT{h>49==577:1:;J;18G591E49H1GE=<;4IJHE<; -->
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_6ME__30-Jun-2013">Brooklyn Cheesecake &amp; Desert Com</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_6ME__30-Jun-2013">0000949721</dei:EntityCentralIndexKey>
<dei:TradingSymbol contextRef="Context_6ME__30-Jun-2013">bcke</dei:TradingSymbol>
<dei:EntityCurrentReportingStatus contextRef="Context_6ME__30-Jun-2013">Yes</dei:EntityCurrentReportingStatus>
<dei:EntityVoluntaryFilers contextRef="Context_6ME__30-Jun-2013">No</dei:EntityVoluntaryFilers>
<dei:CurrentFiscalYearEndDate contextRef="Context_6ME__30-Jun-2013">--12-31</dei:CurrentFiscalYearEndDate>
<dei:EntityFilerCategory contextRef="Context_6ME__30-Jun-2013">Smaller Reporting Company</dei:EntityFilerCategory>
<dei:EntityCommonStockSharesOutstanding contextRef="Context_As_Of__12-Aug-2013" unitRef="shares" decimals="INF">1139284</dei:EntityCommonStockSharesOutstanding>
<dei:DocumentType contextRef="Context_6ME__30-Jun-2013">10-Q</dei:DocumentType>
<dei:AmendmentFlag contextRef="Context_6ME__30-Jun-2013">false</dei:AmendmentFlag>
<dei:DocumentPeriodEndDate contextRef="Context_6ME__30-Jun-2013">2013-06-30</dei:DocumentPeriodEndDate>
<dei:DocumentFiscalYearFocus contextRef="Context_6ME__30-Jun-2013">2013</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="Context_6ME__30-Jun-2013">Q2</dei:DocumentFiscalPeriodFocus>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">1078</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">1078</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">20</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__30-Jun-2012" unitRef="USD" decimals="0">1078</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_1">34350</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_1">40350</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_2">35428</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_2">41428</us-gaap:AssetsCurrent>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_3">25125</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_3">22125</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:AssetsNoncurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_4">25125</us-gaap:AssetsNoncurrent>
<us-gaap:AssetsNoncurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_4">22125</us-gaap:AssetsNoncurrent>
<us-gaap:Assets contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_5">60553</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_5">63553</us-gaap:Assets>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_6">19453</us-gaap:AccountsPayableCurrent>
<us-gaap:AccountsPayableCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_6">19979</us-gaap:AccountsPayableCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_7">17350</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_7">13100</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:DueToOfficersOrStockholdersCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_8">64623</us-gaap:DueToOfficersOrStockholdersCurrent>
<us-gaap:DueToOfficersOrStockholdersCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_8">82769</us-gaap:DueToOfficersOrStockholdersCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_9">101426</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_9">115848</us-gaap:LiabilitiesCurrent>
<us-gaap:PreferredStockValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true" id="Footnote-1_10"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true" id="Footnote-2_10"/>
<us-gaap:CommonStockValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_11">28482</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_11">28482</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_12">13585672</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_12">13585672</us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_13">-13655027</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_13">-13666449</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_14">-40873</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_14">-52295</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0" id="Footnote-1_15">60553</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0" id="Footnote-2_15">63553</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:PreferredStockNoParValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockNoParValue>
<us-gaap:PreferredStockNoParValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockNoParValue>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" xsi:nil="true"/>
<us-gaap:CommonStockNoParValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="3">0.025</us-gaap:CommonStockNoParValue>
<us-gaap:CommonStockNoParValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD_per_Share" decimals="3">0.025</us-gaap:CommonStockNoParValue>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">75000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">75000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">1139284</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">1139284</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">1139284</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">1139284</us-gaap:CommonStockSharesOutstanding>
<us-gaap:LicensesRevenue contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">3000</us-gaap:LicensesRevenue>
<us-gaap:LicensesRevenue contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">6360</us-gaap:LicensesRevenue>
<us-gaap:LicensesRevenue contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">3000</us-gaap:LicensesRevenue>
<us-gaap:LicensesRevenue contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">6000</us-gaap:LicensesRevenue>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">9821</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">18890</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">7829</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">17421</us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:NetIncomeLoss contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">-6821</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-12530</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">-4829</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-11421</us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME__30-Jun-2012" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_6ME__30-Jun-2012" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME__30-Jun-2013" unitRef="USD_per_Share" decimals="2">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_6ME__30-Jun-2013" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME__30-Jun-2012" unitRef="shares" decimals="0">1139284</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_6ME__30-Jun-2012" unitRef="shares" decimals="0">1139284</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME__30-Jun-2013" unitRef="shares" decimals="0">1139284</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_6ME__30-Jun-2013" unitRef="shares" decimals="0">1139284</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:AmortizationOfIntangibleAssets contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">3000</us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:AmortizationOfIntangibleAssets contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">3000</us-gaap:AmortizationOfIntangibleAssets>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">6360</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">6000</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-409</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">525</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-1351</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-4250</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-17650</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-18146</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
<us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">18708</us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders>
<us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">18146</us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">18708</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">18146</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">1058</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">0</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:IncomeTaxesPaidNet contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaidNet contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;1.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Basis of presentation:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. For further information, refer to the financial statements and footnotes thereto included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2012 filed with the Securities and Exchange Commission on April 3, 2013.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results for the full fiscal year ending December 31, 2013.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounting standards have been issued or proposed by the FASB and other standards-setting bodies that are not expected to have a material impact on the financial statements for the period ending June 30, 2013 upon adoption.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<bcke:DescriptionOfBusinessAndGoingConcernTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"  &gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;2.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Description of business and going concern:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company was a manufacturer of baking and confectionery products, which were sold to supermarkets, food distributors, educational institutions, restaurants, mail order and to the public. Although the Company sold its products throughout the United States, its main customer base was on the East Coast of the United States. As of March 2006 the Company has become a holder and licensor of intellectual property.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The accompanying financial statements are prepared assuming the Company will continue as a going concern. At June 30, 2013, the Company had an accumulated deficit of $13,666,449, and a working capital deficiency of $74,420. Additionally, for the six months ended June 30, 2013, the Company incurred a net loss from operations of $11,421 and had net cash used in operations of $18,146. The ability of the Company to continue as a going concern is dependent upon increasing licensing fees and obtaining additional capital and financing. While the Company believes in the viability of its strategy to increase licensing fees and in its ability to raise additional funds, there can be no assurances to that effect.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</bcke:DescriptionOfBusinessAndGoingConcernTextBlock>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"  &gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;3.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Summary of significant accounting policies:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;For the purpose of the statement of cash flows, the Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounts receivable and allowances:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounts receivable are reported at net realizable value. Management considers the need for an allowance for doubtful accounts related to its accounts receivable that are deemed to have potential collectability issues. Management reviews its accounts receivable on a quarterly basis. The Company includes any receivables balances determined to be uncollectible along with a general reserve for doubtful accounts. No allowance was considered necessary at June 30, 2013.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Use of estimates:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The process of preparing financial statements in conformity with generally accepted accounting principles requires the use of estimates and assumptions regarding certain types of assets, liabilities, revenues and expenses. Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements, and includes revenues from licensing fees based on estimates of trademark products sold by our customer. Accordingly, upon settlement, actual results may differ from estimated amounts.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"  &gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Net (Loss) Income per Share:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company computes basic net (loss) income per share based on the weighted average common shares outstanding during the same period. Diluted net (loss) income per share adjusts the weighted average for potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock, which would then share in the earnings of the Company. At June 30, 2013, the Company had no such securities outstanding.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue Recognition:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income from licensing fees are recognized from the sale by our licensee of goods bearing the Brooklyn Cheesecake &amp;amp; Desserts Company, Inc. trademark. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. Fees are computed at 1% of Trademark products sold by our customer.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income Taxes:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax asset and liabilities for the expected future tax consequences of events that have been recognized in the Company&amp;#8217;s financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than changes in the tax law or rates. A valuation allowance is recorded when it is deemed more likely than not that a deferred tax asset will not be realized.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Impairment of Long-Lived Assets:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company reviews long-lived assets for impairment whenever circumstances and situations change such that there is an indication that the carrying amounts may not be recovered. The recoverability of assets held and used in operations is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Fair Value of Financial Instruments:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company&amp;#8217;s financial instruments consist of accounts receivable, accounts payable, accrued expenses, and advances payable. The carrying amounts of the financial instruments reported in the balance sheet approximate fair value based on the short-term maturities of these instruments.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Recent accounting pronouncements:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;4.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Trademark and licensing agreements:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;On March 7, 2002, the Company purchased the rights to the trademark Brooklyn Cheesecake Company, Inc. and Brooklyn Cheesecake and Desserts Company, Inc. and the related corporate logo in exchange for 300,000 shares of the Company&amp;#8217;s common stock, valued on the purchase date at $90,000. The trademark rights are being amortized on the straight-line basis over a fifteen-year term. Amortization expense was $3,000 and $3,000 for the six months ending June 30, 2013 and 2012, respectively.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;On March 28, 2006, the Company entered into a licensing agreement with its former Chairman and CEO, whereby a one percent of sales fee would be charged for the use of the Brooklyn Cheesecake &amp;amp; Desserts Company, Inc. trademark. Licensing fees were $6,000 and $6,360 for the six months ended June 30, 2013 and 2012, respectively.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table align="center" style="width: 60%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2" nowrap="nowrap"&gt;June 30&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2" nowrap="nowrap"&gt;December 31&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center; padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"&gt;2013&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="width: 34%;"&gt;Trademark&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;90,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;90,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Less: Accumulated Amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;(67,875&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;)&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;(64,875&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Trademark, Net&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;22,125&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;25,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="margin-top: 10pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0px;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="text-align: justify; vertical-align: top;"&gt;
&lt;td style="text-align: left; width: 4%;"&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%;"&gt;The &lt;font style="font-size: 10pt;"&gt;following is a schedule of future amortization of the trademark:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white; width: 4%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 65%;"&gt;2013&lt;/td&gt;
&lt;td style="width: 2%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;2014&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style="text-align: right;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;2015&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;2016&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;4,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;22,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
<us-gaap:DebtDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;5.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Advances payable - stockholder:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;During the period ended June 30, 2013, Ronald L. Schutt&amp;#233; the former Chairman and CEO advanced $18,146 to the Company. The advances were used for operating expenses. Total advances through June 30, 2013 were $82,769. These advances bear no interest and are payable on demand.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:DebtDisclosureTextBlock>
<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"  &gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;6.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Business Concentrations&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;During the 3 months ended June 30, 2013 and 2012, the Company derived 100% of its revenues from a single customer. At June 30, 2013 and December 31, 2012, 100% of accounts receivable are due from a single customer. The customer is a related party (Note 7.)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"  &gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="width: 4%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; width: 96%; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;7.&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Related Party Transactions:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;During the three months ended June 30, 2013 and 2012, Ronald Schutte, a former Chairman and Chief Executive Officer of the Company, who is also a Stockholder of the Company, advanced to the Company $0 and $2,250, respectively, for working capital. At June 30, 2013 and December 31, 2012, the Company owed Mr. Schutt&amp;#233; $82,769 and $64,623 respectively. Also see Note 5.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company licenses its trademark to a company controlled by Mr. Schutte and earns licensing fees equal to 1% of sales of products bearing the Brooklyn Cheesecake &amp;amp; Desserts Company, Inc. trademark. During the three months ended June 30, 2013 and 2012, the Company earned license fees from this related party of $3,000 and $3,000 respectively. At June 30, 2013 and December 31, 2012, the Company had accounts receivable from this related party of $40,350 and $34,350, respectively. Also see Note 6.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:FiniteLivedTrademarksGross contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">90000</us-gaap:FiniteLivedTrademarksGross>
<us-gaap:FiniteLivedTrademarksGross contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">90000</us-gaap:FiniteLivedTrademarksGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">64875</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">67875</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">6000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">6000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">6000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">4125</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;For the purpose of the statement of cash flows, the Company considers all short-term debt securities purchased with a maturity of three months or less to be cash equivalents.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounts receivable and allowances:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Accounts receivable are reported at net realizable value. Management considers the need for an allowance for doubtful accounts related to its accounts receivable that are deemed to have potential collectability issues. Management reviews its accounts receivable on a quarterly basis. The Company includes any receivables balances determined to be uncollectible along with a general reserve for doubtful accounts. No allowance was considered necessary at June 30, 2013.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
<us-gaap:UseOfEstimates contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Use of estimates:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The process of preparing financial statements in conformity with generally accepted accounting principles requires the use of estimates and assumptions regarding certain types of assets, liabilities, revenues and expenses. Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements, and includes revenues from licensing fees based on estimates of trademark products sold by our customer. Accordingly, upon settlement, actual results may differ from estimated amounts.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:UseOfEstimates>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Net (Loss) Income per Share:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company computes basic net (loss) income per share based on the weighted average common shares outstanding during the same period. Diluted net (loss) income per share adjusts the weighted average for potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock, which would then share in the earnings of the Company. At June 30, 2013, the Company had no such securities outstanding.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue Recognition:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income from licensing fees are recognized from the sale by our licensee of goods bearing the Brooklyn Cheesecake &amp;amp; Desserts Company, Inc. trademark. The Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. Fees are computed at 1% of Trademark products sold by our customer.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income Taxes:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax asset and liabilities for the expected future tax consequences of events that have been recognized in the Company&amp;#8217;s financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than changes in the tax law or rates. A valuation allowance is recorded when it is deemed more likely than not that a deferred tax asset will not be realized.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Impairment of Long-Lived Assets:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company reviews long-lived assets for impairment whenever circumstances and situations change such that there is an indication that the carrying amounts may not be recovered. The recoverability of assets held and used in operations is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Fair Value of Financial Instruments:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company&amp;#8217;s financial instruments consist of accounts receivable, accounts payable, accrued expenses, and advances payable. The carrying amounts of the financial instruments reported in the balance sheet approximate fair value based on the short-term maturities of these instruments.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleDescription contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 100%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;Recent accounting pronouncements:&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="font: 10pt times new roman, times, serif; vertical-align: top;"&gt;
&lt;td style="font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: justify; font: 10pt times new roman, times, serif;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleDescription>
<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table align="center" style="width: 60%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2" nowrap="nowrap"&gt;June 30&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2" nowrap="nowrap"&gt;December 31&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td style="text-align: center; padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"&gt;2013&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: center;" colspan="2" nowrap="nowrap"&gt;2012&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;" nowrap="nowrap"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="width: 34%;"&gt;Trademark&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;90,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="width: 3%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;90,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;Less: Accumulated Amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;(67,875&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;)&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;(64,875&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Trademark, Net&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;22,125&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;25,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;table style="width: 80%; border-collapse: collapse; font: 10pt times new roman, times, serif;" cellspacing="0" cellpadding="0"&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white; width: 4%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 65%;"&gt;2013&lt;/td&gt;
&lt;td style="width: 2%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right; width: 8%;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;2014&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;2015&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;6,000&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: white; vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;2016&lt;/td&gt;
&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 1pt solid; text-align: right;"&gt;4,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: bottom;"&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="background-color: #cceecc; vertical-align: bottom;"&gt;
&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: left;"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: black 2.5pt double; text-align: right;"&gt;22,125&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
<bcke:WorkingCapitalExcessDeficiency contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">74420</bcke:WorkingCapitalExcessDeficiency>
<us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="Context_0ME_07-Mar-2002" unitRef="shares" decimals="INF">300000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
<us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="Context_0ME_07-Mar-2002" unitRef="USD" decimals="0">90000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="Context_0ME_07-Mar-2002">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<bcke:LicenseAgreementFeeChargedPercentOfSales contextRef="Context_6ME__30-Jun-2013" unitRef="pure" decimals="2">0.01</bcke:LicenseAgreementFeeChargedPercentOfSales>
<us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_BoardOfDirectorsChairmanMember" unitRef="USD" decimals="0">18146</us-gaap:IncreaseDecreaseInDueToOfficersAndStockholdersCurrent>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_3ME__30-Jun-2012_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE__31-Dec-2012_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_3ME__30-Jun-2013_ConcentrationRiskByBenchmarkAxis_SalesRevenueGoodsNetMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_3ME__30-Jun-2013_ConcentrationRiskByBenchmarkAxis_AccountsReceivableMember_ConcentrationRiskByTypeAxis_CustomerConcentrationRiskMember" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="Context_3ME_30-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">2250</us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:ProceedsFromRelatedPartyDebt contextRef="Context_3ME_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="Context_As_Of_31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">64623</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
<us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="Context_As_Of_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">82769</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
<us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="Context_3ME_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember">The Company licenses its trademark to a company controlled by Mr. Schutte and earns licensing feesequal to1% of sales of products bearing the Brooklyn Cheesecake &amp;amp; Desserts Company, Inc. trademark.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
<us-gaap:RevenueFromRelatedParties contextRef="Context_3ME_30-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">3000</us-gaap:RevenueFromRelatedParties>
<us-gaap:RevenueFromRelatedParties contextRef="Context_3ME_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">3000</us-gaap:RevenueFromRelatedParties>
<us-gaap:AccountsReceivableRelatedParties contextRef="Context_As_Of_31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">34350</us-gaap:AccountsReceivableRelatedParties>
<us-gaap:AccountsReceivableRelatedParties contextRef="Context_As_Of_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">40350</us-gaap:AccountsReceivableRelatedParties>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<link:loc xlink:type="locator" xlink:href="#Footnote-1_1" xlink:label="lab_Footnote-1_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_1"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_1" xlink:label="lab_Footnote-2_1"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_1"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_2" xlink:label="lab_Footnote-1_2"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_2"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_2" xlink:label="lab_Footnote-2_2"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_2"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_3" xlink:label="lab_Footnote-1_3"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_3"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_3" xlink:label="lab_Footnote-2_3"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_3"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_4" xlink:label="lab_Footnote-1_4"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_4"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_4" xlink:label="lab_Footnote-2_4"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_4"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_5" xlink:label="lab_Footnote-1_5"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_5"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_5" xlink:label="lab_Footnote-2_5"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_5"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_6" xlink:label="lab_Footnote-1_6"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_6"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_6" xlink:label="lab_Footnote-2_6"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_6"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_7" xlink:label="lab_Footnote-1_7"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_7"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_7" xlink:label="lab_Footnote-2_7"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_7"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_8" xlink:label="lab_Footnote-1_8"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_8"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_8" xlink:label="lab_Footnote-2_8"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_8"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_9" xlink:label="lab_Footnote-1_9"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_9"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_9" xlink:label="lab_Footnote-2_9"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_9"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_10" xlink:label="lab_Footnote-1_10"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_10"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_10" xlink:label="lab_Footnote-2_10"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_10"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_11" xlink:label="lab_Footnote-1_11"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_11"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_11" xlink:label="lab_Footnote-2_11"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_11"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_12" xlink:label="lab_Footnote-1_12"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_12"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_12" xlink:label="lab_Footnote-2_12"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_12"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_13" xlink:label="lab_Footnote-1_13"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_13"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_13" xlink:label="lab_Footnote-2_13"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_13"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_14" xlink:label="lab_Footnote-1_14"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_14"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_14" xlink:label="lab_Footnote-2_14"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_14"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-1_15" xlink:label="lab_Footnote-1_15"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-1" xlink:from="lab_Footnote-1_15"/>
<link:loc xlink:type="locator" xlink:href="#Footnote-2_15" xlink:label="lab_Footnote-2_15"/>
<link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:to="Footnote-2" xlink:from="lab_Footnote-2_15"/>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:label="Footnote-1">Derived from Audited Financial Statements.</link:footnote>
<link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" xlink:label="Footnote-2">(Unaudited)</link:footnote>
</link:footnoteLink>
<xbrli:context id="Context_0ME_07-Mar-2002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2002-03-01</xbrli:startDate><xbrli:endDate>2002-03-07</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_3ME_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-01</xbrli:startDate><xbrli:endDate>2013-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_3ME_30-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-04-01</xbrli:startDate><xbrli:endDate>2012-06-30</xbrli:endDate></xbrli:period></xbrli:context>
	<xbrli:context id="Context_As_Of_30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-06-30</xbrli:instant></xbrli:period></xbrli:context>
	<xbrli:context id="Context_As_Of_31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000949721</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context>
	</xbrli:xbrl>